Why Fear Fails: Limitations of Alarmist Tactics and Humanized Approaches in the  Prevention and Treatment of Anabolic-Androgenic Steroid Abuse

Autores/as

DOI:

https://doi.org/10.69849/hjdqvj26

Palabras clave:

Anabolic agents, health education, health behavior, harm reduction, physician– patient relationships

Resumen

The non-therapeutic use of anabolic-androgenic steroids (AAS) has increased across various  population groups, particularly among young men and gym attendees, constituting a growing  public health challenge. Despite the widespread adoption of fear-based and punitive  campaigns, evidence demonstrates that such strategies are ineffective in reducing use and may  produce adverse effects. Alarmist messages frequently increase stigma, reinforce user  isolation, and reduce the likelihood of seeking medical follow-up. This article critically  analyzes the limitations of fear-based tactics by reviewing experimental studies, qualitative  research, and systematic reviews on the topic. The findings indicate that fear, by failing to  strengthen perceived self-efficacy or promote a sense of personal control, does not effectively  modify beliefs or behaviors. In contrast, balanced educational interventions that integrate  information about risks and benefits, decision-making skills, and harm reduction strategies  show better outcomes in prevention and therapeutic engagement. Programs such as ATLAS  and ATHENA have demonstrated sustained effectiveness by promoting critical thinking and  individual responsibility. Medical training represents another fundamental element: the lack of  specific education in pharmacology and human behavior, combined with institutional censorship, hinders empathetic and evidence-based approaches. It is concluded that addressing  AAS use requires abandoning the moralizing paradigm and adopting policies grounded in  science, education, empathy, and continuous care.

Referencias

1. Bonnecaze AK, O'Connor T, Burns CA. Harm reduction in male patients actively using anabolic androgenic steroids (AAS) and performance-enhancing drugs (PEDs): a review. J Gen Intern Med. 2021;36(7):2055-2064. doi:10.1007/s11606-021-06751-3

2. Kimergård A, McVeigh J. Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UK. BMJ Open. 2014;4(6):e005275. doi:10.1136/bmjopen-2014-005275

3. Harvey O, Keen S, Parrish M, van Teijlingen E. Support for people who use anabolic androgenic steroids: a systematic scoping review into what they want and what they access. BMC Public Health. 2019;19(1):1024. doi:10.1186/s12889-019-7288-x

4. Rogol AD, Yesalis CE 3rd. Anabolic-androgenic steroids and the adolescent. Pediatr Ann. 1992;21(3):175-188. doi:10.3928/0090-4481-19920301-09

5. Petróczi A, Dodge T, Backhouse S, Adesanwo C. Review of the literature on negative health risk-based interventions to guide anabolic steroid misuse prevention. Perform Enhanc Health. 2014;3(4):100-114. doi:10.1016/j.peh.2014.08.001

6. Goldberg L, Bents R, Bosworth E, Trevisan L, Elliot DL. Anabolic steroid education and adolescents: do scare tactics work? Pediatrics. 1991;87(3):283-286

7. Goldberg L, Elliot D, Clarke GN, et al. Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program. JAMA. 1996;276(19):1555-1562. doi:10.1001/jama.1996.03540190027025

8. Ranby KW, Aiken LS, Mackinnon DP, et al. A mediation analysis of the ATHENA intervention for female athletes: prevention of athletic-enhancing substance use and unhealthy weight loss behaviors. J Pediatr Psychol. 2009;34(10):1069-1083. doi:10.1093/jpepsy/jsp025

9. Halliburton AE, Fritz MS. Health beliefs as a key determinant of intent to use anabolic androgenic steroids (AAS) among high-school football players: implications for prevention. Int J Adolesc Youth. 2018;23(3):269-280. doi:10.1080/02673843.2017.1344928

10. Piatkowski T, Gibbs N, Dunn M. Beyond the law: exploring the impact of criminalising anabolic–androgenic steroid use on help-seeking and health outcomes in Australia. J Criminol. 2024;57(1):62-82. doi:10.1177/26338076231209044

11. Vinther AS. “The challenge is that steroids are so effective”: a qualitative study of experts’ views on strategies to prevent men’s use of anabolic steroids. Contemp Drug Probl. 2023;50(1):85-104. doi:10.1177/00914509221129300

12. Izzat N, Abu-Farha R, Harahsheh MM, Thiab S. A qualitative assessment of anabolic androgenic steroid use among gym users in Jordan: motives, perception, and safety. Int J Legal Med. 2023;137(5):1421-1430. doi:10.1007/s00414-023-03046-6

13. Khalili S, Khoshravesh S, Barati M, Mahjoub H, Faradmal J. Androgenic-anabolic steroids use among bodybuilders in western Iran: application of ridge logistic regression model. BMC Sports Sci Med Rehabil. 2023;15(1):7. doi:10.1186/s13102-023-00616-4

14. Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019;104(7):2490-2500. doi:10.1210/jc.2018-01882

15. Jalilian F, Allahverdipour H, Moeini B, Moghimbeigi A. Effectiveness of anabolic steroid preventative intervention among gym users: applying theory of planned behavior. Health Promot Perspect. 2011;1(1):32-40. doi:10.5681/hpp.2011.002

16. Kutscher E, Arshed A, Greene RE, Kladney M. Exploring anabolic androgenic steroid use among cisgender gay, bisexual, and queer men. JAMA Netw Open. 2024;7(5):e2411088. doi:10.1001/jamanetworkopen.2024.11088

17. McVeigh J, Hearne E, Boardley I, et al. Generating evidence on the use of image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network. Harm Reduct J. 2021;18(1):107. doi:10.1186/s12954-021-00550-z

18. Hoffman JR, Ratamess NA. Medical issues associated with anabolic steroid use: are they exaggerated? J Sports Sci Med. 2006;5(2):182-193

19. Kutscher E, Arshed A, Greene RE, Kladney M. Harm reduction techniques among cisgender gay, bisexual, and queer men using anabolic androgenic steroids: a qualitative study. Harm Reduct J. 2024;21(1):196. doi:10.1186/s12954-024-01121-8

20. Vázquez-Mourelle R, Carracedo-Martinez E, Figueiras A. Impact of health authority control measures aimed at reducing the illicit use of anabolic-androgenic steroids. Eur Addict Res. 2018;24(1):28-36. doi:10.1159/000486852

21. Stojko M, Nocoń J, Piłat P, et al. Innovative reports on the effects of anabolic androgenic steroid abuse-how to lose your mind for the love of sport. Medicina (Kaunas). 2023;59(8):1439. doi:10.3390/medicina59081439

22. Piatkowski T, Dunn M. Navigating risks and reducing harm: a gendered analysis of anabolic–androgenic steroid users within the risk environment framework. Contemp Drug Probl. 2024;51(2):111-128. doi:10.1177/00914509241249292

23. Bates G, Van Hout MC, Teck JTW, McVeigh J. Treatments for people who use anabolic androgenic steroids: a scoping review. Harm Reduct J. 2019;16(1):75. doi:10.1186/s12954- 019-0343-1

Publicado

2026-03-08

Cómo citar

Câmara, L. C., & Ferreira, M. H. L. (2026). Why Fear Fails: Limitations of Alarmist Tactics and Humanized Approaches in the  Prevention and Treatment of Anabolic-Androgenic Steroid Abuse. Revista Ft, 30(156), 01-13. https://doi.org/10.69849/hjdqvj26